IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Mar 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-02-27

Reporting Person: PARSHALL B LYNNE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-27	Common Stock	M	8333	$39.87	Acquired	61010	Direct
2019-02-27	Common Stock	S	8333	$70.00	Disposed	52677	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-27	Employee Stock Option (right to buy)	$39.87	M	8333	Acquired	2021-01-01	Common Stock (8333)	Direct

Footnotes

F1: Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/8/2017.